Your browser doesn't support javascript.
loading
Systematic review and meta-analysis of post-progression outcomes in ER+/HER2- metastatic breast cancer after CDK4/6 inhibitors within randomized clinical trials.
Munzone, E; Pagan, E; Bagnardi, V; Montagna, E; Cancello, G; Dellapasqua, S; Iorfida, M; Mazza, M; Colleoni, M.
Afiliação
  • Munzone E; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: elisabetta.munzone@ieo.it.
  • Pagan E; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
  • Bagnardi V; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
  • Montagna E; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy.
  • Cancello G; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy.
  • Dellapasqua S; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy.
  • Iorfida M; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy.
  • Mazza M; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy.
  • Colleoni M; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy; Program of Breast Health European Institute of Oncology, IRCCS, Milan, Italy.
ESMO Open ; 6(6): 100332, 2021 12.
Article em En | MEDLINE | ID: mdl-34864350
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Antineoplásicos Hormonais / Inibidores de Proteínas Quinases Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: ESMO Open Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Antineoplásicos Hormonais / Inibidores de Proteínas Quinases Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: ESMO Open Ano de publicação: 2021 Tipo de documento: Article